CSF1 and breast cancer: By targeting CSF1, miR-149 inhibits CSF1 dependent communication between TNBC cells and THP-1 macrophages, thereby blocking the paracrine interactions between MDA-MB-231 cells and THP-1 cells and inhibiting breast cancer metastasis (Sanchez-Gonzalez et al., 2020).